The role and reversibility of vascular alterations in the development, progression and regression of metabolic dysfunction-associated steatotic liver disease (MASLD)
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,259 p.
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Source
JHEP Reports - ISSN 2589-5559-8:4 (2026) p. 1-11
SBP: always peritonitis in decompensated cirrhosis? Case report and review of the literature
Source
Acta gastro-enterologica belgica - ISSN 1784-3227-88:4 (2025) p. 361-365
STRONG II trial : stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma – a single-arm multicentre phase II study
Source
BMJ open - ISSN 2044-6055-15:7 (2025) p. 1-11
Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease
Source
Cardiovascular diabetology - ISSN 1475-2840-24:1 (2025) p. 1-11